Skip to main content
Global Edition
Tuesday, April 23, 2024

Moderna GMK 102320

Credit: WTVQ Lexington, KY
Duration: 0 shares 4 views

Moderna GMK 102320
Moderna GMK 102320

One of the companies working on a coronavirus vaccine says they have finished enrollment for a phase three study.

And have set prices at $32-37 per dose.

Price vaccine at $32-$37 per dose meanwhile--one of the companies working on a coronavirus vaccine said wednesday ... has finished enrollment for a phase three study.

Moderna also said it plans to make the vaccine affordable -- below 40-dollars per dose for most customers.

Two other companies --novavax and pfizer have also had promising vaccine

You might like